MPM Asset Management Investors BV2014 LLC
SEC CIK 1609495 · EDGAR
BoughtSold
Most active insiders at HOWL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | EVNIN LUKE | Dir | — | $3.26M |
| 2 | MPM BioVentures 2014 LLC | 10% | — | $1.09M |
| 3 | RA CAPITAL MANAGEMENT, L.P. | 10% | — | $963.9K |
| 4 | UBS Oncology Impact Fund L.P. | 10% | — | $824.5K |
| 5 | MPM Asset Management Investors BV2014 LLC | 10% | — | $528.5K |
| 6 | MPM Oncology Innovations Fund GP LLC | 10% | — | $528.1K |
| 7 | MPM BioImpact LLC | Former 10% Owner | — | $479.1K |
| 8 | MPM ONCOLOGY INNOVATIONS FUND LP | 10% | — | $391.6K |
| 9 | MPM BioVentures 2014, L.P. | 10% | — | $241.3K |
| 10 | MPM BioVentures 2014 (B), L.P. | Former 10% Owner | — | $183.3K |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-12-01 | 2025-11-26+ | HOWL | Werewolf Therapeutics, Inc. | MPM Asset Management Investors BV2014 LLC | 10% | S - Sale | $0.9643 | -141.9K | 5.07M | -3% | -$136.9K |
| MI | 2025-11-03 | 2025-10-30+ | HOWL | Werewolf Therapeutics, Inc. | MPM Asset Management Investors BV2014 LLC | 10% | S - Sale | $1.33 | -295.0K | 6.36M | -4% | -$391.6K |
| DI | 2025-04-30 | 2025-03-27 | HOWL | Werewolf Therapeutics, Inc. | MPM Asset Management Investors BV2014 LLC | 10% | X - OptEx | $0.09 | +22.8K | 3.21M | +0.7% | +$2,048 |
| DI | 2025-04-30 | 2025-03-27 | HOWL | Werewolf Therapeutics, Inc. | MPM Asset Management Investors BV2014 LLC | 10% | S - Sale+OE | $1.05 | -1,963 | 3.21M | -0.1% | -$2,061 |
| DMI | 2021-11-04 | 2021-11-02 | TRDA | Entrada Therapeutics, Inc. | MPM Asset Management Investors BV2014 LLC | 10% | C - Cnv Deriv | — | +4.33M | 4.33M | New | — |
| DI | 2021-11-04 | 2021-11-02 | TRDA | Entrada Therapeutics, Inc. | MPM Asset Management Investors BV2014 LLC | 10% | P - Purchase | $20.00 | +100.0K | 4.43M | +2% | +$2.00M |
Purchase Sale Sale after option exercise All abbreviations